Background
Mycoplasma hominis is a small free-living organism belonging to the genus Mycoplasma [1] . Mycoplasma lacks a rigid cell wall and therefore cannot be visualized by routine light microscopy [1] . Moreover, the lack of a cell wall prevents visualization of Mycoplasma species by Gram staining and makes the organism resistant to cell wall inhibitors such as beta-lactam antibiotics [1] [2] [3] . It is very challenging and resource-and time-consuming to diagnose infections caused by this organism because of the requirement for special selective medium and specific incubation conditions for culturing M. hominis [4] . Furthermore, there are few biochemical traits that are valuable for diagnosis [4] . Accordingly, matrixassisted laser desorption ionization-time-of-flight mass spectrometry (MALDI-TOF MS) has been adopted as a cost-effective, rapid, reliable method for the diagnosis of M. hominis [5] .
M. hominis generally colonizes the urogenital tracts of sexually active adults and is a causative organism of urogenital tract infections [1] . Central nervous system (CNS) infections due to M. hominis are rare. To best of our knowledge, only 21 cases of CNS infection caused by M. hominis, including our current case, have been reported in the literature.
Here, we present a successfully treated case of M. hominis ventriculitis secondary to extraventricular drain. This is the first case of M. hominis causing CNS infection reported in a country in the Middle East.
Case Report
A 25-year-old man was admitted to the emergency room as a victim of a motor vehicle crash. His Glasgow coma score was 8/15, and he was therefore electively intubated and attached to mechanical ventilation. Whole-body computed tomography (CT) was performed, yielding the following findings: CT of the spine showed a nondisplaced compression fracture at the ninth and 10 th thoracic vertebrae; CT of the chest showed bilateral basal atelectasis/consolidation likely related to aspiration, with bilateral ground-glass opacities and nondisplaced manubrium sternal fracture; CT of the abdomen showed a small (0.5 cm) contusion over the spleen; CT of the head showed an acute left subdural hemorrhage with underlying mild brain edema and a right midline shift of approximately 1 cm.
Based on these findings, emergency decompressive craniectomy with extraventricular drain (EVD) insertion was performed. He was then admitted to the surgical intensive care unit (SICU) and maintained on mechanical ventilation. On day 5, he developed fever with leukocytosis; septic workup, including cerebral spinal fluid (CSF) analysis and culture, indicated EVD-related ventriculitis, and the patient was administered vancomycin and meropenem. However, the antibiotic regimen was adjusted based on culture results (Table 1) , and the patient received a full course of lipid-formulated amphotericin B and vancomycin (for Candida albicans and Staphylococcus hemolyticus).
After 8 days, the EVD was removed. Four days later, he developed deterioration of consciousness, and a new CT scan of the brain showed active hydrocephalus ( Figure 1 ) with a worsening midline shift. Hence, another EVD was inserted, and a full septic workup was performed (Table 1) .
On day 18, he underwent debridement at the cephalic surgical site, and a full course of ceftazidime was administered owing to wound infection. On day 25, the patient underwent tracheostomy placement. Postoperatively, he became febrile, and his Glasgow coma scale remained at 8/15. Leukocytosis (14.3 k/µL) was also observed, and another septic screening was performed; the results of CSF culture revealed M. hominis ( Table 1 ). The same isolate regrew from a confirmatory sample on day 28. The next day, the second EVD was changed, and he was administered intravenous ciprofloxacin 400 mg every 8 h for a total duration of 14 days. On day 39, the patient was clinically improved and transferred to the general ward. The third EVD remained in place until day 45. He was maintained on nasogastric feeding and tracheostomy. A few days later, he was transferred to another health care facility upon his employer's request. The patient did not follow up with our facility after that.
Microbiology laboratory findings
Yellowish clear CSF samples from EVD were inoculated on sheep blood agar, MacConkey agar, chocolate agar, anaerobic blood agar, and thioglycolate broth, incubated at 37°C according to the internal policies and procedures of the microbiology laboratory at King Fahd Hospital of the University. CSF analysis revealed a white blood cell count of 1430/cu mm, with 82% segmented cells, a protein value of 316 mg/dL, and a glucose level of 3.0 mg/dL. Direct Gram stain smears from samples showed few pus cells and no organisms. After 48 h of incubation, there was growth of nonhemolytic, translucent, pinpoint colonies on anaerobic blood agar only (Figure 2 ). Gram stain smears from colonies showed no evidence of bacteria. The isolate was identified as M. hominis using MALDI-TOF-MS (VITEK MS; bioMérieux) and Knowledge Base database (version 3.0), with a confidence value of 99.9. Subsequent CSF samples also grew colonies of M. hominis. Table 1 summarizes CSF laboratory results for the patient during admission.
Discussion
M. hominis primarily colonizes the respiratory tract and genitourinary tract. This organism is mainly transmitted to humans through obstruction of the urinary tract, sexual contact, and vertical transmission in utero or intrapartum [1, 3] . Surface antigenic variation of M. hominis may be related to the persistence of these organisms at invasive sites [1] . Most infections caused by M. hominis are primarily related to genital tract colonization.
The infections caused by this organism include acute pyelonephritis, cervicitis, endometritis, tubal factor infertility, postabortion bacteremia, bacterial vaginosis, and other genital tract infections. Other reportable clinical conditions caused by M. hominis include bacteremia after renal transplantation, trauma, and genitourinary manipulations; osteomyelitis; septic arthritis; aspiration associated-empyema; peritonitis; intra-abdominal abscesses; and wound infections [1, 3] . In the early 1980s, M. hominis infections were also reported following organ transplantation and immunosuppressive therapy. These infections most likely originated from the patient's normal flora [4] .
M. hominis has also been reported from brain abscesses and meningitis. Several cases of CNS infection by M. hominis have been described in premature infants with prolonged rupture of the membranes, probably owing to genital colonization of pregnant women. These neonates usually present with mild, subclinical meningitis without sequelae or neurological damage with permanent handicaps [1, 3] . In adults, rare cases of M. hominis meningitis have been described mainly following neurosurgery manipulations [3, 6, 7] . Moreover, few cases of M. hominis infection following ventriculoperitoneal shunt insertion with central nervous system involvement have been reported [7, 8] . In general, CNS infections with M. hominis usually resolve spontaneously [3] . Existing literature on patients with CNS infection caused by M. hominis is summarized in Table 2 . Isolation of M. hominis in any quantity from sterile body fluids is significantly associated with disease, and identification at the species level is necessary [1] . The optimal temperature for M. hominis growth is between 35 and 37°C, and these organisms grow best under anaerobic conditions, usually within 1-5 days of incubation [3] . M. hominis can be detected routinely in bacteriologic culture medium, such as chocolate agar or blood agar; accordingly, there have been many instances of incidental discovery when Mycoplasma species were not specifically sought [3] . MALDI-TOF MS is a rapid, reliable, cost-effective method and has been shown to accurately identify most Mycoplasma species, particularly M. hominis [1, 5] .
Mycoplasma species are innately resistant to all beta-lactams, sulfonamides, trimethoprim, and rifampin. M. hominis is usually susceptible to tetracycline, fluoroquinolone, clindamycin, chloramphenicol, streptomycin, and gentamicin [1, 3] . Some strains of M. hominis have been reported to be resistant erythromycin, fluoroquinolone, and tetracycline. The extent to which tetracycline resistance occurs in M. hominis varies geographically and may
